Read more

November 29, 2023
1 min read
Save

Top in endocrinology: Heart benefits of Mediterranean diet; tackling statin intolerance

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Eating foods associated with the Mediterranean diet was linked to a reduced risk for CVD, particularly among women, a recent study showed.

Researchers said the findings “support the notion that the consumption of a Mediterranean diet may be beneficial for cardiovascular health, including in non-Mediterranean settings.” It was the top story in endocrinology last week.

Mediterranean Diet Foods
Eating foods associated with the Mediterranean diet was linked to a reduced risk for CVD, particularly among women, a recent study showed. Image Source: Adobe Stock

The second top story was about treatment strategies for statin-intolerant patients who have or are at risk for atherosclerotic CVD.

Read these and more top stories in endocrinology below:

Mediterranean diet linked to improvements in CV health

Adults who eat more foods associated with a Mediterranean diet have lower BP, BMI and reduced cardiovascular risk, according to study findings published in Nutrition, Metabolism & Cardiovascular Diseases. Read more.

Educate, explore options to limit risks for statin-intolerant patients

Statin therapy is a first-line recommendation for all adults with established atherosclerotic CVD or at high atherosclerotic CVD risk, yet reports show many patients cannot — or will not — take statins as prescribed. Read more.

Hybrid closed-loop system lowers severe hypoglycemia, DKA rates in type 1 diabetes

Children and adults using a hybrid closed-loop insulin delivery system had fewer cases of severe hypoglycemia and diabetic ketoacidosis than what was previously observed in historical data, according to study findings. Read more.

Teprotumumab reduces proptosis in long-standing, stable thyroid eye disease

Adults with long-standing thyroid eye disease and low clinical activity scores had greater reductions in proptosis with teprotumumab compared with placebo, according to data published in The Journal of Clinical Endocrinology & Metabolism. Read more.

BLOG: Milestones and life stories to celebrate World Diabetes Day

The International Diabetes Federation’s World Diabetes Day is a time to recognize the burdens of diabetes and celebrate the hard work by people living with diabetes as they deal with their sugars on a 24-hour basis. Read more.